We are live on ! Find out more
4WM

49 Wealth Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.81%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
+$121M
Cap. Flow
+$87.4M
Cap. Flow %
8.24%
Top 10 Hldgs %
70.46%
Holding
209
New
31
Increased
96
Reduced
67
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 3.18%
2 Financials 1.2%
3 Energy 0.79%
4 Consumer Staples 0.74%
5 Communication Services 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN icon
176
Lennar Class A
LEN
$20.4B
$219K 0.02%
+1,737
New +$216K
JMBS icon
177
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.74B
$218K 0.02%
4,782
+61
+1% +$2.75K
VWO icon
178
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$218K 0.02%
+4,025
New +$207K
SPDW icon
179
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.3B
$215K 0.02%
+5,035
New +$209K
USAC icon
180
USA Compression Partners
USAC
$3.69B
$210K 0.02%
8,753
+114
+1% +$2.75K
ROKU icon
181
Roku
ROKU
$21.6B
$208K 0.02%
2,077
-1,005
-33% -$92.7K
URI icon
182
United Rentals
URI
$65.7B
$208K 0.02%
+218
New +$194K
INTU icon
183
Intuit
INTU
$91.1B
$206K 0.02%
+301
New +$217K
IBTF
184
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
$204K 0.02%
8,722
-225,507
-96% -$5.26M
VOE icon
185
Vanguard Mid-Cap Value ETF
VOE
$23.9B
$202K 0.02%
+1,156
New +$197K
MASS icon
186
908 Devices
MASS
$312M
$168K 0.02%
19,188
COGT icon
187
Cogent Biosciences
COGT
$6.76B
$144K 0.01%
10,043
-5,465
-35% -$64.7K
EVH icon
188
Evolent Health
EVH
$371M
$116K 0.01%
13,761
-5,539
-29% -$53.7K
NRIX icon
189
Nurix Therapeutics
NRIX
$2.45B
$108K 0.01%
+11,678
New +$121K
PGP
190
PIMCO Global StockPLUS & Income Fund
PGP
$96.6M
$107K 0.01%
+12,499
New +$105K
GAB icon
191
Gabelli Equity Trust
GAB
$1.73B
$82.2K 0.01%
+13,494
New +$81K
RLAY icon
192
Relay Therapeutics
RLAY
$4B
$68.4K 0.01%
+13,101
New +$50K
AURA icon
193
Aura Biosciences
AURA
$725M
$65.6K 0.01%
+10,609
New +$69.4K
ZNTL icon
194
Zentalis Pharmaceuticals
ZNTL
$332M
$42.6K ﹤0.01%
28,192
+6,646
+31% +$9.96K
ANNX icon
195
Annexon
ANNX
$796M
$36.9K ﹤0.01%
12,083
RMCO icon
196
Royalty Management
RMCO
$34.1M
$25.2K ﹤0.01%
11,896
+21
+0.2% +$35
LUNG icon
197
Pulmonx
LUNG
$52.8M
$23.4K ﹤0.01%
+14,455
New +$30.2K
BFLY icon
198
Butterfly Network
BFLY
$1.86B
$22.1K ﹤0.01%
+11,433
New +$19.4K
INZY
199
DELISTED
Inozyme Pharma
INZY
-40,675
Closed -$163K
KO icon
200
Coca-Cola
KO
$383B
-21,146
Closed -$1.5M

Similar funds

49 Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, 49 Wealth Management held 209 positions worth $1.06B, up 13% from $939M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

49 Wealth Management deployed $87.4M of net new capital in Q3 2025, opening 31 new positions and adding to 96 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 75,734 shares worth $6.05M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.3% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Global X 1-3 Month T-Bill ETF, an estimated $16.7M trimmed.

  • 49 Wealth Management's largest Q3 2025 buy was Vanguard Short-Term Corporate Bond ETF: 75,734 shares worth $6.05M.
  • 49 Wealth Management added most to Vanguard Short-Term Treasury ETF in Q3 2025, an estimated $35.3M increase.
  • 49 Wealth Management's biggest Q3 2025 reduction was Global X 1-3 Month T-Bill ETF, cutting an estimated $16.7M.
  • 49 Wealth Management fully exited Coca-Cola in Q3 2025, selling an estimated $1.5M.
  • 49 Wealth Management's ten largest holdings make up 70% of its $1.06B portfolio in Q3 2025.
  • 49 Wealth Management opened 31 new positions and closed 11 in Q3 2025.
  • 49 Wealth Management's portfolio value rose 13% quarter-over-quarter to $1.06B.

Based on 49 Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.